PRADELLI, Lorenzo; VILLA, Sara; CASTAMAN, Giancarlo. Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 19, n. 1, 2018. DOI: 10.7175/fe.v19i1.1328. Disponível em: https://provafe.seedstm.com/index.php/FE/article/view/1328. Acesso em: 23 jul. 2025.